XML 73 R61.htm IDEA: XBRL DOCUMENT v3.21.2
SHAREHOLDERS EQUITY (Details Narrative) - USD ($)
9 Months Ended
Feb. 11, 2021
Sep. 30, 2021
Dec. 31, 2020
Reverse stock split   reverse stock split of our common stock and our Convertible Series A Preferred Stock, in each case, at a ratio of 1-for-8 and without any change to the respective par value thereof (the “Reverse Stock Split”), and, on September 10, 2020  
Common stock par value $ 0.01    
Aggregate cash consideration $ 314,500    
Common stock share sold   2,869,442  
Warrant issued   $ 1,434,721  
Proceeds from issuance of warrants   $ 4,581,651  
Exercise price of warrant   $ 1.68  
Warrant amendment, description In connection with the Warrant Amendment, TOMI repurchased the warrant from Dr. Shane (the “Repurchase”) for an aggregate cash consideration of $314,500, representing a 15% discount of the net exercise cash value of the Warrant, which was calculated using the closing price of the Common Stock on the Nasdaq on February 11, 2021 of $5.36, less the exercise price of the warrants in the amount of $2.40. On the same date, the Warrant Amendment and the Repurchase was considered, approved and adopted by a disinterested majority of TOMI’s board of directors.    
Common stock value   $ 196,810 $ 167,615
Private Placement [Members]      
Warrant issued   $ 1,434,721  
Exercise price of warrant   $ 1.68  
Placement Agent [Members]      
Warrant issued   $ 172,167  
Exercise price of warrant   $ 2.18  
January 2020 [Member]      
Common stock shares fully vested, shares   50,000  
Common stock shares fully vested, amount   $ 48,000  
March 2020 [Member]      
Common stock shares issued upon conversion of convertible notes payable, shares   1,041,667  
Common stock shares issued upon conversion of convertible notes payable, amount   $ 4,500,000  
Common stock shares issued upon exercise of warrants, shares   10,417  
Common stock shares issued upon exercise of warrants, amount   $ 57,500  
July 2020 [Member]      
Common stock shares issued upon exercise of warrants, shares   26,940  
Common stock shares issued upon exercise of warrants, amount   $ 62,500  
June 2020 [Member]      
Common stock shares issued upon exercise of warrants, shares   26,940  
Common stock shares issued upon exercise of warrants, amount   $ 62,500  
May 2020 [Member]      
Common stock shares issued upon exercise of option, shares   2,500  
Common stock shares issued upon exercise of option, amount   $ 1,000  
January 2021 [Member]      
Common stock share issued   50,000  
Common stock value   $ 228,000  
Cumulative Convertible Series A Preferred Stock      
Cumulative Convertible Preferred Stock; Shares Authorized   1,000,000 1,000,000
Cumulative Convertible Preferred Stock; Shares Issued   63,750 63,750
Cumulative Convertible Preferred Stock; Shares Outstanding   63,750 63,750
Cumulative Convertible Preferred Stock; Par Value   $ 0.01 $ 0.01
Cumulative Convertible Series B Preferred Stock      
Cumulative Convertible Preferred Stock; Shares Authorized   4,000 4,000
Cumulative Convertible Preferred Stock; Shares Issued   0 0
Cumulative Convertible Preferred Stock; Shares Outstanding   0 0
Cumulative Convertible Preferred Stock; Par Value   $ 1,000 $ 1,000
Stock Options | January 2020 [Member] | CEO [Member]      
Volatility rate   135.00%  
Expected dividend yield   0.00%  
Risk free interest rate   1.64%  
Aggregate shares purchase of stock option   31,250  
Fair value of stock option   $ 23,595  
Grant fair value of per share   $ 0.80  
Exercise price   $ 0.96  
Stock Warrant [Member] | January 2020 [Member] | CEO [Member]      
Volatility rate   136.00%  
Expected dividend yield   0.00%  
Risk free interest rate   1.64%  
Grant fair value of per share   $ 1.04  
Exercise price   $ 1.20  
Warrants issued upon purchase share of common stock   156,250  
Fair value of stock warrant   $ 164,201  
Stock Warrant [Member] | February 2020 [Member] | CEO [Member]      
Volatility rate   155.00%  
Expected dividend yield   0.00%  
Risk free interest rate   1.64%  
Grant fair value of per share   $ 0.96  
Exercise price   $ 1.20  
Warrants issued upon purchase share of common stock   18,750  
Fair value of stock warrant   $ 18,571  
Stock Warrant [Member] | April 2020 [Member] | CEO [Member]      
Volatility rate   173.00%  
Expected dividend yield   0.00%  
Risk free interest rate   0.68%  
Grant fair value of per share   $ 4.00  
Exercise price   $ 4.00  
Warrants issued upon purchase share of common stock   12,500  
Fair value of stock warrant   $ 49,693  
Stock Warrant 1 [Member] | January 2020 [Member] | CEO [Member]      
Volatility rate   135.00%  
Expected dividend yield   0.00%  
Risk free interest rate   1.58%  
Grant fair value of per share   $ 0.72  
Exercise price   $ 0.96  
Warrants issued upon purchase share of common stock   5,208  
Fair value of stock warrant   $ 3,594  
Stock Warrant 1 [Member] | April 2020 [Member] | CEO [Member]      
Volatility rate   173.00%  
Expected dividend yield   0.00%  
Risk free interest rate   0.68%  
Grant fair value of per share   $ 4.00  
Exercise price   $ 4.00  
Warrants issued upon purchase share of common stock   6,250  
Fair value of stock warrant   $ 24,846  
Stock Warrant 2 [Member] | April 2020 [Member] | CEO [Member]      
Volatility rate   173.00%  
Expected dividend yield   0.00%  
Risk free interest rate   0.68%  
Grant fair value of per share   $ 4.00  
Exercise price   $ 4.00  
Warrants issued upon purchase share of common stock   6,250  
Fair value of stock warrant   $ 24,846  
Stock Warrant 3 [Member] | April 2020 [Member] | CEO [Member]      
Volatility rate   173.00%  
Expected dividend yield   0.00%  
Risk free interest rate   0.68%  
Grant fair value of per share   $ 4.00  
Exercise price   $ 4.00  
Warrants issued upon purchase share of common stock   3,750  
Fair value of stock warrant   $ 14,908